IE880860L - Dopamine-beta-hydroxylase inhibitors - Google Patents

Dopamine-beta-hydroxylase inhibitors

Info

Publication number
IE880860L
IE880860L IE86088A IE86088A IE880860L IE 880860 L IE880860 L IE 880860L IE 86088 A IE86088 A IE 86088A IE 86088 A IE86088 A IE 86088A IE 880860 L IE880860 L IE 880860L
Authority
IE
Ireland
Prior art keywords
dopamine
beta
hydroxylase inhibitors
hydroxylase
inhibitors
Prior art date
Application number
IE86088A
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Priority to IE86088A priority Critical patent/IE880860L/en
Publication of IE880860L publication Critical patent/IE880860L/en

Links

IE86088A 1988-03-23 1988-03-23 Dopamine-beta-hydroxylase inhibitors IE880860L (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IE86088A IE880860L (en) 1988-03-23 1988-03-23 Dopamine-beta-hydroxylase inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IE86088A IE880860L (en) 1988-03-23 1988-03-23 Dopamine-beta-hydroxylase inhibitors

Publications (1)

Publication Number Publication Date
IE880860L true IE880860L (en) 1988-09-24

Family

ID=11019049

Family Applications (1)

Application Number Title Priority Date Filing Date
IE86088A IE880860L (en) 1988-03-23 1988-03-23 Dopamine-beta-hydroxylase inhibitors

Country Status (1)

Country Link
IE (1) IE880860L (en)

Similar Documents

Publication Publication Date Title
ZA884838B (en) Dopamine-beta-hydroxylase inhibitors
ZA883851B (en) Dopamine-beta-hydroxylase inhibitors
PT83076A (en) Dopamine-beta-hydroxylase inhibitors
HU906389D0 (en) New alpha-glycosidase inhibitors
ZA874396B (en) Irreversible dopamine-beta-hydroxylase inhibitors
PT83628A (en) Dopamine-beta-hydroxylase inhibitors
ZA889709B (en) Dopamine-beta-hydroxylase inhibitors
ZA889667B (en) Dopamine-beta-hydroxylase inhibitors
ZA873653B (en) Dopamine-beta-hydroxylase inhibitors
ZA8892B (en) Dopamine-beta-hydroxylase inhibitors
ZA882100B (en) Dopamine-beta-hydroxylase inhibitors
PT85596B (en) Dopamine-beta-hydroxylase inhibitors
AU4553889A (en) Dopamine-beta-hydroxylase inhibitors
ZA868234B (en) Dopamine-beta-hydroxylase inhibitors
AU4553689A (en) Dopamine-beta-hydroxylase inhibitors
ZA86949B (en) Dopamine-beta-hydroxylase inhibitors
IE882030L (en) Dopamine-beta-hydroxylase inhibitors
IE880860L (en) Dopamine-beta-hydroxylase inhibitors
ZA882275B (en) Dopamine-beta-hydroxylase inhibitors
IE883872L (en) Dopamine-beta-hydroxylase inhibitors.
IE893832L (en) DOPAMINE-ß-HYDROXYLASE INHIBITORS
ZA842963B (en) Dopamine-beta-hydroxylase inhibitors
ZW4285A1 (en) Dopamine-beta-hydroxylase inhibitors
ZA842962B (en) Dopamine-beta-hydroxylase inhibitors
IE883871L (en) Dobamine-beta-hydroxylase inhibitors.